English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Danielle Pacey
| Nov 14, 2018
Study examines inhaled insulin for treating Type 1 diabetes
Press release submission
| Nov 7, 2018
PROMIS NEUROSCIENCES, INC: Discusses Critical Importance of Selectively Targeting the Root Cause of Alzheimer’s Disease
Press release submission
| Nov 7, 2018
PARTNER THERAPEUTICS: Receives FDA Orphan Drug Designation for Leukine® for the Treatment of Pulmonary Alveolar Proteinosis
Press release submission
| Nov 4, 2018
ALKERMES: Reports on Outcome of FDA Advisory Committee Meeting on ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder
Press release submission
| Nov 4, 2018
U.S. FOOD AND DRUG ADMINISTRATION: FDA permits marketing of two devices that detect parathyroid tissue in real-time during surgery
Press release submission
| Oct 26, 2018
ABBVIE: To Assume Full Development and Commercial Control of Cystic Fibrosis Research Program
Press release submission
| Oct 26, 2018
ABBOTT: Introduces the Next Generation of Influenza A & B and Strep A Assays with Fastest-Ever Time to Molecular Results
Karen Kidd
| Oct 23, 2018
Think tank founder recommends standard patents over intellectual property rights to cut drug prices
Trending
Patient Daily
| Jul 8, 2025
Clinical assistant professor at Stanford: ‘Musical background is associated with better performance of fundamental surgical skills'
+
Pharmaceuticals
Patient Daily
| Jul 10, 2025
PhRMA Executive VP: ‘State policymakers can lead the way and must address 340B abuse and protect patients from PBMs'
+
Pharmaceuticals
Patient Daily
| Jul 8, 2025
Psychedelic mushrooms' compound shows potential antiaging effects
Patient Daily
| Jul 9, 2025
FDA approves Longeveron's Phase 2 study for pediatric dilated cardiomyopathy treatment
« First
«
…
101
102
103
104
105
106
107
…
»
Last »